Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radiation Therapy, Secondary Skin Reactions”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Large-scale testing (Phase 3)Study completedNCT00006481
What this trial is testing

Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerSkin Reactions Secondary to Radiation Therapy
Radiation Therapy Oncology Group
Not applicableWithdrawnNCT02168179
What this trial is testing

KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituSkin Reactions Secondary to Radiation TherapyStage IA Breast Cancer+4 more
Wake Forest University Health Sciences
Not applicableUnknownNCT01022086
What this trial is testing

Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab

Who this might be right for
Stage I-IV Breast Cancer (Neo-adjuvant, Adjuvant, Locally Advanced and Metastatic)
Unity Health Toronto 50
Testing effectiveness (Phase 2)Looking for participantsNCT05732051
What this trial is testing

Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients

Who this might be right for
Breast CancerMetastatic Breast CancerCancer Therapy-Related Cardiac Dysfunction+2 more
University Hospital, Akershus 60
Post-approval studies (Phase 4)Looking for participantsNCT05465031
What this trial is testing

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Who this might be right for
Breast CancerNeoplasm, BreastBreast Diseases+10 more
Silesian Centre for Heart Diseases 600
Testing effectiveness (Phase 2)Study completedNCT01487954
What this trial is testing

Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy

Who this might be right for
Radiation ToxicityRecurrent Breast CancerStage I Breast Cancer+5 more
Case Comprehensive Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT00377559
What this trial is testing

Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer

Who this might be right for
Breast CancerNeoplasm Metastasis
Catharina Ziekenhuis Eindhoven 70
Large-scale testing (Phase 3)Looking for participantsNCT03418961
What this trial is testing

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Who this might be right for
CardiotoxicityHER2/Neu PositiveMetastatic Malignant Neoplasm in the Brain+2 more
SWOG Cancer Research Network 491
Not applicableActive Not RecruitingNCT05036252
What this trial is testing

Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity

Who this might be right for
Breast CancerHER2-positive Breast CancerHER2-positive Metastatic Breast Cancer+5 more
Memorial Sloan Kettering Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT02203565
What this trial is testing

Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy

Who this might be right for
Breast CancerSkin Reactions Secondary to Radiation Therapy
Stanford University 20
Testing effectiveness (Phase 2)Ended earlyNCT01120171
What this trial is testing

Myocet Plus Endoxan for Older Patients With Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 64
Testing effectiveness (Phase 2)Ended earlyNCT00377780
What this trial is testing

Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer

Who this might be right for
Breast CancerNeoplasm Metastasis
Laurence J.C. van Warmerdam 60
Not applicableStudy completedNCT00599989
What this trial is testing

Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer

Who this might be right for
Breast CancerLong-term Effects Secondary to Cancer Therapy in AdultsSkin Reactions Secondary to Radiation Therapy
Abramson Cancer Center at Penn Medicine 28
Not applicableStudy completedNCT01407770
What this trial is testing

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer

Who this might be right for
Breast CancerCognitive Ability, GeneralFatigue+4 more
Wake Forest University Health Sciences 1,000
Not applicableLooking for participantsNCT03711110
What this trial is testing

Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)

Who this might be right for
Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)ElderlyAntineoplastic Agents+1 more
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León 514
Not applicableUnknownNCT02101879
What this trial is testing

Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With Trastuzumab ,Pertuzumab and Taxanes

Who this might be right for
Cardiotoxicity.Anti Her2 Therapy.Metastatic Breast Cancer
Rambam Health Care Campus 20
Large-scale testing (Phase 3)Study completedNCT00438659
What this trial is testing

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Who this might be right for
Breast CancerDermatologic ComplicationsRadiation Toxicity+1 more
North Central Cancer Treatment Group 176
Not applicableUnknownNCT06016361
What this trial is testing

Evaluation of a Novel Amino Acid Based Moisturizing Cream as Part of the Daily Standard Skincare Regimen Recommended During Radiation Therapy

Who this might be right for
ErythemaRadiation Therapy, Secondary Skin Reactions
Entrinsic Bioscience Inc. 70